Schedule 13D ownership disclosure
PSYENCE BIOMEDICAL LTD
Common Stock, without par value · CUSIP: 74449F308
Event date: 2026-01-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- KAOS Capital Ltd.Reported CIK 0002100448
Shares: 313,876.00 · Class: 4.91%
- Adam ArvivReported CIK 0002100451
Shares: 313,876.00 · Class: 4.91%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001539497-26-000044
- Form type
- SCHEDULE 13D/A
- Filer
- Kaos Capital Ltd
- CIK
- CIK 2100448
- Filed
- Jan 13, 2026
- Reporting period
- Jan 08, 2026
- Description
- Schedule 13D beneficial ownership